Skip to content
Screener

QuidelOrtho Corporation QDEL Domestic — Total revenues

Similar metrics at other companies

Citizens logo
CIADomestic Insurance Segment — Total revenues
$20.51M+7.9%
PROG Holdings logo
PRGOther revenue — Total revenues
$39.4M+134%
LanzaTech Global, Inc. logo
LNZABiorefining revenue — Total revenues
$6.98M+145%
FTAI Aviation Ltd. logo
FTAIMaintenance revenue — Total revenues
$30.6M-38.3%
FTAI Aviation Ltd. logo
FTAIOther revenue — Total revenues
$6.21M+19,923%
Vir Biotechnology, Inc. logo
VIRGrant revenue — Total revenues
$11K-94.0%

Other financials

Income statement

See full
Revenue$630.9M+2.8%
Gross profit$272.9M-0.7%
Operating income-$21.8M+87.9%
Net income-$92.9M+63.6%
EPS (diluted)-$1.36+63.9%

Balance sheet

See full
Cash & equivalents$123.4M-18.7%
Total debt$3.4B+3.0%
Total equity$1.8B-36.4%
Total assets$5.7B-10.4%

Cash flow

See full
Operating cash flow-$110.6M
CapEx$25.5M-32.0%
Free cash flow-$136.1M-61.4%

Valuation

See full
Market cap$942.91M-41.3%
Enterprise value$4.25B-11.2%
P/S0.4×-0.2×

Profitability

See full
Gross margin44.6%-2.7pp
Operating margin-30.8%-49.9pp
Net margin-39.2%-168pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-45.9%-94.9pp
Debt / equity1.9×+0.7×
Current ratio1.4×+0.3×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: QuidelOrtho Corporation’s 10-K, filed February 19, 2026.

Filed
Feb 18, 2026, 9:45 PM EST
Fiscal year
FY2025
Accession
0001906324-26-000008
(In millions)Long-lived Assets as of / December 28, 2025Long-lived Assets as of / December 29, 2024Total Revenues for Fiscal Year Ended / 2025Total Revenues for Fiscal Year Ended / 2024Total Revenues for Fiscal Year Ended / 2023
Domestic$829.2$947.8$1,436.6$1,568.8$1,829.4
Foreign529.1432.41,293.61,214.11,168.4
Total$1,358.3$1,380.2$2,730.2$2,782.9$2,997.8

Item 8. Financial Statements and Supplementary Data

FAQ

What is QuidelOrtho Corporation's domestic — total revenues?
QuidelOrtho Corporation (QDEL) reported domestic — total revenues of $359.15M in Q4 2025.
How has QuidelOrtho Corporation's domestic — total revenues changed year-over-year?
QuidelOrtho Corporation's domestic — total revenues decreased by 8.4% year-over-year, from $392.2M to $359.15M.
What is the long-term trend for QuidelOrtho Corporation's domestic — total revenues?
Over 3 years (2022 to 2025), QuidelOrtho Corporation's domestic — total revenues has grown at a -16.3% compound annual growth rate (CAGR), from $2.45B to $1.44B.
What does domestic — total revenues mean?
Measures the total gross income generated from the sale of diagnostic testing solutions and services within the domestic market. This figure reflects the company's market penetration and demand for its immunoassay, molecular, and clinical chemistry products in its primary geographic region. It is a critical indicator of the company's ability to maintain its domestic market share and revenue stability.

Ask your AI about QuidelOrtho Corporation's domestic — total revenues.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude